Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Specificity protein 1 (Sp1)-DNA complex is a critical regulatory assembly formed when the Sp1 transcription factor binds to GC-rich motifs, known as GC boxes, within the promoter regions of numerous genes [1]. Sp1 utilizes its three C-terminal Cys2His2-type zinc finger domains to recognize and bind these sequences, facilitating the recruitment of the basal transcription machinery and other co-activators to initiate gene expression [1, 3]. This complex plays a pivotal role in regulating essential cellular processes, including the cell cycle, apoptosis, and angiogenesis [3]. In many pathological states, particularly in various cancers and viral infections like HIV-1, Sp1 is often overexpressed or hyperactive, driving the transcription of oncogenes and viral proteins [2, 3]. Consequently, the Sp1-DNA complex has emerged as a therapeutic target, with drugs like Mithramycin A acting as DNA-binding agents that displace Sp1 from its cognate sites [2, 4]. However, because Sp1 regulates a vast array of housekeeping genes, targeting this complex presents significant challenges regarding systemic toxicity and off-target effects [3, 4]. (Sources: [1] UniProt P08047; [2] PMID: 11509595; [3] PMID: 24013078; [4] PMID: 17189388)
Competitive inhibition of transcription factor binding to DNA by small molecules that occupy the GC-rich minor groove or modify the DNA structure, thereby preventing the recruitment of the transcriptional machinery.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Specificity protein 1-DNA complex (Sp1-DNA complex).